1492 Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evolent Health
EVH
|
+$1.67M |
| 2 |
CTLP
Cantaloupe
CTLP
|
+$1.17M |
| 3 |
TherapeuticsMD
TXMD
|
+$1.05M |
| 4 |
Corcept Therapeutics
CORT
|
+$1.04M |
| 5 |
NTUS
Natus Medical Inc
NTUS
|
+$852K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWFT
Swift Transportation Company
SWFT
|
+$2.98M |
| 2 |
Ciena
CIEN
|
+$2.31M |
| 3 |
SAVE
Spirit Airlines, Inc.
SAVE
|
+$2.21M |
| 4 |
Hackett Group
HCKT
|
+$1.85M |
| 5 |
WAGE
WageWorks, Inc.
WAGE
|
+$1.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.6% |
| 2 | Healthcare | 19.8% |
| 3 | Industrials | 12.13% |
| 4 | Consumer Discretionary | 8.55% |
| 5 | Financials | 8.1% |
Similar funds
1492 Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, 1492 Capital Management held 109 positions worth $113M, down 0.28% from $113M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
1492 Capital Management withdrew a net $7.98M in Q3 2017, closing 17 positions and reducing 67 holdings. Its most notable exit was Swift Transportation Company, an estimated $2.98M position sold in full.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, 1492 Capital Management opened a new position in Corcept Therapeutics worth $1.35M.
- 1492 Capital Management's largest Q3 2017 buy was Corcept Therapeutics: 70,034 shares worth $1.35M.
- 1492 Capital Management added most to Evolent Health in Q3 2017, an estimated $1.67M increase.
- 1492 Capital Management's biggest Q3 2017 reduction was Matador Resources, cutting an estimated $708K.
- 1492 Capital Management fully exited Swift Transportation Company in Q3 2017, selling an estimated $2.98M.
- 1492 Capital Management's ten largest holdings make up 34% of its $113M portfolio in Q3 2017.
- 1492 Capital Management opened 10 new positions and closed 17 in Q3 2017.
- 1492 Capital Management's portfolio value fell 0.28% quarter-over-quarter to $113M.
Based on 1492 Capital Management's 13F filing for Q3 2017, filed 9 Nov 2017.